Hormone Molecular Biology and Clinical Investigation

期刊简介：Hormone Molecular Biology and Clinical Investigation (HMBCI) is dedicated to the provision of basic data on molecular aspects of hormones in physiology and pathophysiology. The journal covers the treatment of major diseases, such as endocrine cancers (breast, prostate, endometrium, ovary), renal and lymphoid carcinoma, hypertension, cardiovascular systems, osteoporosis, hormone deficiency in menopause and andropause, obesity, diabetes, brain and related diseases, metabolic syndrome, sexual dysfunction, fetal and pregnancy diseases, as well as the treatment of dysfunctions and deficiencies. HMBCI covers new data on the different steps and factors involved in the mechanism of hormone action. It will equally examine the relation of hormones with the immune system and its environment, as well as new developments in hormone measurements.

【译文】激素分子生物学和临床研究 (HMBCI) 致力于提供生理学和病理生理学中激素分子方面的基本数据。该杂志涵盖内分泌癌（乳腺癌、前列腺癌、子宫内膜癌、卵巢癌）、肾癌和淋巴癌、高血压、心血管系统、骨质疏松症、更年期和男性更年期激素缺乏、肥胖、糖尿病、脑及相关疾病、代谢综合征、性功能障碍、胎儿和妊娠疾病等重大疾病的治疗，以及功能障碍和缺陷的治疗。 HMBCI 涵盖了激素作用机制中涉及的不同步骤和因素的新数据。它将同样研究激素与免疫系统及其环境的关系，以及激素测量的新进展。